GRM5 and fragile X syndrome: In FXS mice, CRISPR‐mediated knockout of mGluR5 in the striatum of FXS mice was sufficient to rescue exaggerated repetitive behaviours (Lee, Lee, et al., 2018), raising the potential that gene therapy against mGluR5 could be successful where drugs have failed.